High-content imaging technology for the evaluation of drug-induced steatosis using a multiparametric cell-based assay.
about
High Content Imaging (HCI) on Miniaturized Three-Dimensional (3D) Cell CulturesIdentification of Inhibitors of triacylglyceride accumulation in muscle cells: comparing HTS results from 1536-well plate-based and high-content platformsHigh-content screening technology for studying drug-induced hepatotoxicity in cell models.The development of high-content screening (HCS) technology and its importance to drug discovery.High Content Analysis of Human Pluripotent Stem Cell Derived Hepatocytes Reveals Drug Induced Steatosis and Phospholipidosis.Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies.A metabolomics cell-based approach for anticipating and investigating drug-induced liver injury.Effects of Nano-CeO₂ with Different Nanocrystal Morphologies on Cytotoxicity in HepG2 CellsA simple transcriptomic signature able to predict drug-induced hepatic steatosis.A lipidomic cell-based assay for studying drug-induced phospholipidosis and steatosis.A Multi-Parametric Fluorescent Assay for the Screening and Mechanistic Study of Drug-Induced Steatosis in Liver Cells in Culture.Editor's Highlight: Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis.Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury.LC-MS untargeted metabolomic analysis of drug-induced hepatotoxicity in HepG2 cells.In vitro/in vivo screening of oxidative homeostasis and damage to DNA, protein, and lipids using UPLC/MS-MS.Multiparametric evaluation of the cytoprotective effect of the Mangifera indica L. stem bark extract and mangiferin in HepG2 cells.Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
P2860
Q26773298-88A0A21C-63AE-41A4-9E4F-BC1ACDB9017CQ30421866-A1063F31-80F9-4F85-9F4C-C5D910E28195Q38383132-285E46D4-0D06-432B-957B-85B8A708E41DQ38772165-D9CEBDE7-953E-4F1C-855F-FA39812396B1Q38793908-4346B715-BF7C-455B-8A2C-957EBEF312D5Q39034431-2F841952-7CB7-4743-8679-E529B2FB5DF8Q39707536-18144715-C302-4CE3-967D-D81DA0F2D0DFQ40504248-B038E309-4602-4CAE-AA99-170C8F107724Q42707141-9C05722A-8D12-41C0-AD91-E8723159BD6AQ46364739-719F7946-F9CD-4B63-86FB-F2DE771D84DEQ46373398-BA97A75E-AE53-4E8F-99E7-8823724DA0D2Q47807772-E336F68F-FA9C-44C4-9393-1B239968E08CQ49219661-E9816851-426A-4A23-9C52-78FDAC32BFE5Q50443932-1D8C4842-83ED-44E3-98EA-07FD7E2D5691Q50467662-236A06D7-2F97-4685-961C-89B67475BCAAQ50935127-A1CA9A61-FE5C-44BB-AF9F-6E3608E73F27Q53085870-CC549347-5A0B-412C-93D3-4A049F36C48A
P2860
High-content imaging technology for the evaluation of drug-induced steatosis using a multiparametric cell-based assay.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
High-content imaging technolog ...... tiparametric cell-based assay.
@ast
High-content imaging technolog ...... tiparametric cell-based assay.
@en
High-content imaging technolog ...... tiparametric cell-based assay.
@nl
type
label
High-content imaging technolog ...... tiparametric cell-based assay.
@ast
High-content imaging technolog ...... tiparametric cell-based assay.
@en
High-content imaging technolog ...... tiparametric cell-based assay.
@nl
prefLabel
High-content imaging technolog ...... tiparametric cell-based assay.
@ast
High-content imaging technolog ...... tiparametric cell-based assay.
@en
High-content imaging technolog ...... tiparametric cell-based assay.
@nl
P2093
P2860
P356
P1476
High-content imaging technolog ...... tiparametric cell-based assay.
@en
P2093
José V Castell
Laia Tolosa
M José Gómez-Lechón
M Teresa Donato
Nuria Jiménez
P2860
P304
P356
10.1177/1087057111427586
P577
2011-11-23T00:00:00Z